{"id":41556,"date":"2026-03-26T22:47:43","date_gmt":"2026-03-26T22:47:43","guid":{"rendered":"https:\/\/beyondtype1.org\/la-fda-aprueba-minimed-flex\/"},"modified":"2026-03-26T22:49:19","modified_gmt":"2026-03-26T22:49:19","slug":"fda-aprueba-minimed-flex","status":"publish","type":"resources","link":"https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/","title":{"rendered":"La FDA aprueba MiniMed Flex."},"content":{"rendered":"<p><span style=\"font-weight: 400;\">&iquest;Buscas una bomba de insulina m&aacute;s discreta para el verano? Est&aacute;s de suerte: a principios de esta semana, la Administraci&oacute;n de Alimentos y Medicamentos (FDA, pos sus siglas en ingl&eacute;s) <\/span><a href=\"https:\/\/news.minimed.com\/2026-03-18-MiniMed-Announces-FDA-Clearance-of-MiniMed-Flex-TM-,-the-Companys-Smallest-Insulin-Pump-Featuring-Its-First-Smartphone-Controlled-Design\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">aprob&oacute; el MiniMed Flex<\/span><\/a><span style=\"font-weight: 400;\">,la bomba de insulina m&aacute;s peque&ntilde;a de la compa&ntilde;&iacute;a y la primera que se controla mediante una aplicaci&oacute;n para tel&eacute;fonos inteligentes. Esto marca la primera aprobaci&oacute;n de la FDA para MiniMed como empresa independiente de Medtronic. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">La MiniMed Flex tiene aproximadamente la mitad del tama&ntilde;o de la bomba de insulina MiniMed 780G y est&aacute; dise&ntilde;ada para integrarse perfectamente en la vida de las personas con diabetes,<\/span> permitiendo <a href=\"https:\/\/beyondtype1.org\/all-about-insulin\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">la dosificaci&oacute;n de insulina<\/span><\/a> <span style=\"font-weight: 400;\">directamente desde el tel&eacute;fono inteligente.<\/span> <span style=\"font-weight: 400;\">El sistema MiniMed Flex est&aacute; aprobado para personas de 7 a&ntilde;os o m&aacute;s con diabetes tipo 1 y para personas de 18 a&ntilde;os o m&aacute;s con diabetes tipo 2 que requiere de insulina.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">&laquo;En MiniMed, nuestra misi&oacute;n es mejorar la vida diaria de las personas con diabetes&raquo;, afirm&oacute; Que Dallara, director ejecutivo de MiniMed. &laquo;MiniMed Flex representa esa promesa. Est&aacute; dise&ntilde;ado para funcionar de forma silenciosa y fiable en segundo plano, con automatizaci&oacute;n avanzada integrada en una bomba compacta controlada por smartphone. El resultado es una tecnolog&iacute;a que permite a las personas dedicar menos tiempo al control de la diabetes y m&aacute;s tiempo a disfrutar de su vida&raquo;. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">La MiniMed Flex utiliza el algoritmo SmartGuard con tecnolog&iacute;a de detecci&oacute;n de comidas, que ayuda a las personas a controlar los niveles de az&uacute;car en sangre antes, durante y despu&eacute;s de comer. El producto puede utilizar cualquiera de los dos <\/span><a href=\"https:\/\/beyondtype1.org\/es\/simplera-sync-aprobado-fda-minimed-780g\/\"><span style=\"font-weight: 400;\">El monitor continuo de glucosa (MCG) Simplera Sync<\/span><\/a> <span style=\"font-weight: 400;\">o el<\/span> <a href=\"https:\/\/beyondtype1.org\/es\/instinct-mcg-medtronic\/\"><span style=\"font-weight: 400;\">MCG Instinct, fabricado por Abbott<\/span><\/a> <span style=\"font-weight: 400;\">, ofrecen mayor flexibilidad a los pacientes.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Algunas de las nuevas caracter&iacute;sticas del<\/span> <a href=\"https:\/\/www.minimed.com\/en-us\/products\/minimed-flex-system\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">MiniMed Flex<\/span><\/a> <span style=\"font-weight: 400;\">incluyen:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Dise&ntilde;o compacto con alta capacidad de insulina: el elegante dise&ntilde;o del dep&oacute;sito de insulina de 300 unidades es ideal si desea una bomba de insulina discreta pero que a la vez satisfaga diversas necesidades de insulina.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Controlado mediante smartphone: la bomba de insulina se gestiona a trav&eacute;s de una aplicaci&oacute;n m&oacute;vil, lo que elimina la pantalla tradicional de la bomba. Las actualizaciones de software se env&iacute;an directamente a su dispositivo iOS o Android. <\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Compatibilidad flexible con sensores de MCG: el MiniMed Flex puede utilizar el sensor Simplera Sync CGM o el sensor Instinct para mayor flexibilidad y opciones por parte del usuario.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Capacidades de set de infusi&oacute;n extendidas: el nuevo sistema funciona con la gama de sets de infusi&oacute;n de MiniMed, incluido el set de infusi&oacute;n extendido, que permite hasta 7 d&iacute;as de uso.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Rendimiento de la administraci&oacute;n automatizada de insulina, con<\/span> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40824839\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">pacientes que alcanzan el 80 % del tiempo en rango (TiR)<\/span><\/a> <span style=\"font-weight: 400;\">con los ajustes recomendados.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">&laquo;MiniMed Flex representa un importante avance para MiniMed&raquo;, afirm&oacute; el Dr. Anders Carlson, director m&eacute;dico del Centro Internacional de Diabetes de Park Nicollet, director del Programa de Diabetes de HealthPartners y profesor adjunto de la Facultad de Medicina de la Universidad de Minnesota. &laquo;Para muchas personas con diabetes, la gesti&oacute;n diaria puede resultar abrumadora. Al combinar un dise&ntilde;o discreto y sin pantalla con un potente algoritmo adaptativo que responde r&aacute;pidamente a los cambios en la glucosa, MiniMed Flex aporta una innovaci&oacute;n significativa justo donde se necesita: en la vida cotidiana&raquo;. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">MiniMed tambi&eacute;n ha lanzado el programa MiniMed Forward, que permite a los clientes actualizar su bomba de insulina MiniMed 780G a MiniMed Flex sin costo adicional. Si su bomba MiniMed ya est&aacute; en garant&iacute;a, recibir&aacute; una notificaci&oacute;n cuando la MiniMed Flex est&eacute; disponible comercialmente en Estados Unidos, con opciones para actualizarla. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">El lanzamiento del sistema MiniMed Flex comenzar&aacute; con un grupo selecto de pacientes de MiniMed en la primavera de 2026, seguido de un lanzamiento comercial a gran escala este verano. <\/span><\/p>\n\n","protected":false},"excerpt":{"rendered":"<p>&iquest;Buscas una bomba de insulina m&aacute;s discreta para el verano? Est&aacute;s de suerte: a principios de esta semana, la Administraci&oacute;n de Alimentos y Medicamentos (FDA, pos sus siglas en ingl&eacute;s) aprob&oacute; el MiniMed Flex,la bomba de insulina m&aacute;s peque&ntilde;a de la compa&ntilde;&iacute;a y la primera que se controla mediante una aplicaci&oacute;n para tel&eacute;fonos inteligentes. Esto [&hellip;]<\/p>\n","protected":false},"author":26,"featured_media":41528,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-41556","resources","type-resources","status-publish","has-post-thumbnail","hentry","content-categories-noticias","topics-tecnologia-y-equipamiento","diabetes-types-diabetes-gestacional","diabetes-types-tipo-1","diabetes-types-tipo-2","tags-bomba-de-insulina-para-la-diabetes","tags-diabetes-e-insulina","tags-diabetes-tipo-1","tags-manejo-de-la-diabetes","tags-tecnologia-para-la-diabetes"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La FDA aprueba MiniMed Flex. | Beyond Type 1<\/title>\n<meta name=\"description\" content=\"MiniMed Flex, aprobada por la FDA, es la bomba de insulina m\u00e1s peque\u00f1a de Medtronic, que cuenta con administraci\u00f3n automatizada de insulina y control total mediante tel\u00e9fono inteligente.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La FDA aprueba MiniMed Flex. | Beyond Type 1\" \/>\n<meta property=\"og:description\" content=\"MiniMed Flex, aprobada por la FDA, es la bomba de insulina m\u00e1s peque\u00f1a de Medtronic, que cuenta con administraci\u00f3n automatizada de insulina y control total mediante tel\u00e9fono inteligente.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/\" \/>\n<meta property=\"og:site_name\" content=\"Beyond Type 1\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/beyondtype1\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-26T22:49:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2026\/03\/BT1_Article-Header_Minimed-Flex-Gets-FDA-Approval_V2_2026.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1380\" \/>\n\t<meta property=\"og:image:height\" content=\"776\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@BeyondType1\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/\",\"url\":\"https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/\",\"name\":\"La FDA aprueba MiniMed Flex. | Beyond Type 1\",\"isPartOf\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2026\/03\/BT1_Article-Header_Minimed-Flex-Gets-FDA-Approval_V2_2026.jpg\",\"datePublished\":\"2026-03-26T22:47:43+00:00\",\"dateModified\":\"2026-03-26T22:49:19+00:00\",\"description\":\"MiniMed Flex, aprobada por la FDA, es la bomba de insulina m\u00e1s peque\u00f1a de Medtronic, que cuenta con administraci\u00f3n automatizada de insulina y control total mediante tel\u00e9fono inteligente.\",\"breadcrumb\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/#primaryimage\",\"url\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2026\/03\/BT1_Article-Header_Minimed-Flex-Gets-FDA-Approval_V2_2026.jpg\",\"contentUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2026\/03\/BT1_Article-Header_Minimed-Flex-Gets-FDA-Approval_V2_2026.jpg\",\"width\":1380,\"height\":776},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/beyondtype1.org\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La FDA aprueba MiniMed Flex.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#website\",\"url\":\"https:\/\/beyondtype1.org\/es\/\",\"name\":\"Beyond Type 1\",\"description\":\"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.\",\"publisher\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/beyondtype1.org\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#organization\",\"name\":\"Beyond Type 1\",\"url\":\"https:\/\/beyondtype1.org\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg\",\"contentUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg\",\"width\":56,\"height\":56,\"caption\":\"Beyond Type 1\"},\"image\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/beyondtype1\",\"https:\/\/x.com\/BeyondType1\",\"http:\/\/instagram.com\/BeyondType1\/\",\"https:\/\/www.youtube.com\/c\/BeyondType1\",\"https:\/\/www.tiktok.com\/@beyondtype1\",\"https:\/\/www.linkedin.com\/company\/beyond-type1\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La FDA aprueba MiniMed Flex. | Beyond Type 1","description":"MiniMed Flex, aprobada por la FDA, es la bomba de insulina m\u00e1s peque\u00f1a de Medtronic, que cuenta con administraci\u00f3n automatizada de insulina y control total mediante tel\u00e9fono inteligente.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/","og_locale":"es_ES","og_type":"article","og_title":"La FDA aprueba MiniMed Flex. | Beyond Type 1","og_description":"MiniMed Flex, aprobada por la FDA, es la bomba de insulina m\u00e1s peque\u00f1a de Medtronic, que cuenta con administraci\u00f3n automatizada de insulina y control total mediante tel\u00e9fono inteligente.","og_url":"https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/","og_site_name":"Beyond Type 1","article_publisher":"https:\/\/www.facebook.com\/beyondtype1","article_modified_time":"2026-03-26T22:49:19+00:00","og_image":[{"width":1380,"height":776,"url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2026\/03\/BT1_Article-Header_Minimed-Flex-Gets-FDA-Approval_V2_2026.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@BeyondType1","twitter_misc":{"Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/","url":"https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/","name":"La FDA aprueba MiniMed Flex. | Beyond Type 1","isPartOf":{"@id":"https:\/\/beyondtype1.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/#primaryimage"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/#primaryimage"},"thumbnailUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2026\/03\/BT1_Article-Header_Minimed-Flex-Gets-FDA-Approval_V2_2026.jpg","datePublished":"2026-03-26T22:47:43+00:00","dateModified":"2026-03-26T22:49:19+00:00","description":"MiniMed Flex, aprobada por la FDA, es la bomba de insulina m\u00e1s peque\u00f1a de Medtronic, que cuenta con administraci\u00f3n automatizada de insulina y control total mediante tel\u00e9fono inteligente.","breadcrumb":{"@id":"https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/#primaryimage","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2026\/03\/BT1_Article-Header_Minimed-Flex-Gets-FDA-Approval_V2_2026.jpg","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2026\/03\/BT1_Article-Header_Minimed-Flex-Gets-FDA-Approval_V2_2026.jpg","width":1380,"height":776},{"@type":"BreadcrumbList","@id":"https:\/\/beyondtype1.org\/es\/fda-aprueba-minimed-flex\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/beyondtype1.org\/es\/"},{"@type":"ListItem","position":2,"name":"La FDA aprueba MiniMed Flex."}]},{"@type":"WebSite","@id":"https:\/\/beyondtype1.org\/es\/#website","url":"https:\/\/beyondtype1.org\/es\/","name":"Beyond Type 1","description":"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.","publisher":{"@id":"https:\/\/beyondtype1.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/beyondtype1.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/beyondtype1.org\/es\/#organization","name":"Beyond Type 1","url":"https:\/\/beyondtype1.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","width":56,"height":56,"caption":"Beyond Type 1"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/beyondtype1","https:\/\/x.com\/BeyondType1","http:\/\/instagram.com\/BeyondType1\/","https:\/\/www.youtube.com\/c\/BeyondType1","https:\/\/www.tiktok.com\/@beyondtype1","https:\/\/www.linkedin.com\/company\/beyond-type1\/"]}]}},"_links":{"self":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/41556","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/comments?post=41556"}],"version-history":[{"count":2,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/41556\/revisions"}],"predecessor-version":[{"id":41558,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/41556\/revisions\/41558"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media\/41528"}],"wp:attachment":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media?parent=41556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}